Posts tagged: market
Attacking Antibiotic Resistant Tuberculosis With Drugs Already On The Market
A two-drug combination is one of the most promising advances in decades for the treatment of tuberculosis (TB) - a disease that kills 2 million people annually - a scientist reported at the 243 National Meeting & Exposition of the American Chemical Society (ACS). The treatment, which combines two medications ...
FMBFarma granted exclusive rights to market Ampio’s Zertane for PE in Brazil
Ampio Pharmaceuticals, Inc., a company that discovers and develops new uses for previously approved drugs and new molecular entities, and FBM Industria Farmaceutica Ltda, a member of the HOSPFAR Group that manufactures, imports and distributes pharmaceuticals in Brazil, today announced a license and distribution agreement providing FMBFarma exclusive rights to ...
Heightened Security Threats and Economic Issues Provide Fillip to Global Civil and Military Biometrics Market, Says Frost & Sullivan
LONDON, March 21, 2012 /- The universal adoption of biometric passports will influence eGate implementation which will become the main revenue generator for the global civil and military biometrics market in the near future. In addition, portable devices used by the police and the military will become a common tool in ...
Global MDI market to grow at 6.1% CAGR to $16.0 billion in 2016
According to a new market report published by Transparency Market Research "Methylene Diphenyl Diisocyanate Market: Global Market Analysis, Size, Share & Forecast (2009 - 2016)", Global MDI market was worth USD 11.9 billion in 2011 and is expected to reach USD 16.0 billion in 2016, growing at a CAGR of ...
Teva gets exclusive 180 days to market generic antidepressant and anti-anxiety pill Lexapro
Teva Pharmaceutical Industries Ltd. Has won U.S. approval to sell the first generic version of Lexapro for depression and anxiety. Teva has been granted a 180-day exclusivity, so no other firm can market the generic medication in the United States in that timeframe, the Food and Drug Administration (FDA) said ...
Pharma Pricing & Market Access Outlook Europe 2012, 20-23 March, London
Health Network Communications recently interviewed Stefanie Thomas, Drug Assessment, IQWiG on what she thought the top issues impacting pharmaceutical market access were, and how she addressed these issues. Ms Thomas believes the top 3 issues impacting pharmaceutical market access are:"Maintenance of affordable high-quality health care; area of conflict between early ...
The Poor Exploited By Growing Market For Human Organs
A Michigan State University anthropologist who spent more than a year infiltrating the black market for human kidneys has published the first in-depth study describing the often horrific experiences of poor people who were victims of organ trafficking. Monir Moniruzzaman interviewed 33 kidney sellers in his native Bangladesh and found ...
Growing market for human organs exploits poor
(Michigan State University) A Michigan State University anthropologist who spent more than a year infiltrating the black market for human kidneys has published the first in-depth study describing the often horrific experiences of poor people who were victims of organ trafficking.
Nordic Market Access, Pricing & Reimbursement Conference 8-9 May 2012, Stockholm, Sweden
This conference is the only event looking directly at ongoing reforms regarding pricing, reimbursement and funding of drugs specifically for the Nordic countries. Payers and HTAs will discuss how they are appraising health technologies, defining value, making reimbursement decisions, and following these up in practice. Leading pharma companies will present ...
Pharmaceutical And Medical Device Market Access In Key Asian Markets Conference, 23-24 May 2012, Singapore
Reacting to new developments to optimize pricing and marketing approaches for fast-growing and complex Eastern markets Asian markets are increasingly the focus of pharmaceutical companies who are looking for new market opportunities beyond the traditional "rich-world" countries who are facing economic stagnation...
Nordion celebrates first anniversary of market launch of TheraSphere
Nordion Inc., a leading provider of products and services to the global health science market, today celebrated the first anniversary of the market introduction of TheraSphere, an innovative radioembolic liver cancer therapy, in the Republic of Turkey.